Download App
PAPER TRADE
Download App
Login
Feedback
ASTRAZEN
newsbot
Reputation: 200,282 •
Sep 17, 2020 11:06 PM
It is ridiculous to build DRL earnings expectations based on Russia vaccine tieup: Sandip Sabharwal
‘ The Russian vaccine is not an approved vaccine and hardly any trials have taken place.
The Economic Times
https://economictimes.indiatimes.com/markets/expert-view/...
#ASTRAZEN
Vote
Comment
Share
NSE:ASTRAZEN price when posted: 4,256